33 studies found for:    eplerenone | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Eplerenone for the Treatment of Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Interventions: Drug: 25mg Eplerenone;   Drug: Placebo
2 Recruiting The Effect of EPLerenone on Ischemia Reperfusion Injury in Human myoCARDium
Condition: Ischemia-reperfusion Injury
Interventions: Drug: Eplerenone;   Other: Aldosterone
3 Recruiting Eplerenone for Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention: Drug: Eplerenone 50mg
4 Not yet recruiting A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Interventions: Drug: Eplerenone;   Drug: Maltodextrin
5 Recruiting Eplerenone in HIV Associated Abdominal Fat Accumulation
Condition: HIV
Interventions: Drug: Eplerenone and lifestyle;   Other: placebo and lifestyle
6 Recruiting Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Eplerenone
7 Not yet recruiting Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis (MIRACULOUS) Trial
Condition: Atherosclerosis
Intervention: Drug: Eplerenone
8 Unknown  CMR to Assess Fibrosis in Cardiomyopathy Using Eplerenone
Condition: Cardiomyopathy
Interventions: Drug: Eplerenone;   Drug: Placebo
9 Recruiting EPLErenone in CsA-Treated Recipients (EpleCsAT): Safety
Conditions: Chronic Kidney Insufficiency;   Kidney Transplantation
Intervention: Drug: Eplerenone
10 Recruiting Clinical Study Of Eplerenone In Japanese Patients With Chronic Heart Failure
Condition: Heart Failure
Interventions: Drug: Eplerenone;   Drug: Placebo
11 Recruiting The Effects of Eplerenone on Markers of Myocardial Fibrosis in Adult Congenital Heart Disease
Conditions: Tetralogy of Fallot;   Transposition of the Great Vessels With an Arterial Switch;   Single Ventricle With a Fontan Palliation
Intervention: Drug: Eplerenone
12 Recruiting Comparison of Effects of Eplerenone Versus Spironolactone in Heart Failure Patients With Glucose Intolerance or Type 2 Diabetes
Conditions: Heart Failure;   Type 2 Diabetes;   Glucose Intolerance
Interventions: Drug: Eplerenone;   Drug: Spironolactone
13 Recruiting Eplerenone and Aliskiren Research Targeting Hypertensive Patients With Left Ventricular Hypertrophy
Condition: Hypertensive Left Ventricular Hypertrophy
Interventions: Drug: Aliskiren;   Drug: Eplerenone
14 Recruiting The EPOCH Study (Eplerenone on Top of ACE Inhibition in Chronic Kidney Disease Patients With Hypertension)
Condition: CKD II-III
Interventions: Drug: Eplerenone;   Drug: Placebo
15 Recruiting Eplerenone Versus Spironolactone as Treatment of Ascites Due to Liver Cirrhosis; a Study of Efficacy and Side Effects
Conditions: Ascites;   Cirrhosis
Intervention: Drug: Eplerenone
16 Not yet recruiting CLCNKA (Ka Renal Chloride Channel[ClC-Ka]) Polymorphism Effects on Hypertrophy Regression
Condition: Hypertension
Interventions: Drug: Eplerenone;   Drug: placebo
17 Unknown  Does Aldosterone Cause Hypertension by a Non-Renal Mechanism?
Conditions: Hypertension;   Dialysis;   Hyperaldosteronism
Interventions: Drug: Eplerenone;   Drug: Placebo
18 Recruiting The Role of Aldosterone on Augmented Exercise Pressor Reflex in Hypertension
Condition: Hypertension
Interventions: Drug: Eplerenone;   Drug: Amlodipine;   Procedure: Microneurography;   Procedure: Rhythmic handgrip exercise;   Procedure: Sustained hand grip;   Procedure: Forearm blood flow;   Procedure: Arm cycling exercise;   Procedure: Cold Pressor test
19 Recruiting Eplerenone For the Treatment of Chronic Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention: Drug: Eplerenone
20 Recruiting Phase IIb Safety and Efficacy Study of BAY94-8862 in Subjects With Worsening Chronic Heart Failure and Left Ventricular Systolic Dysfunction and Either Type 2 Diabetes Mellitus With or Without Chronic Kidney Disease or Moderate Chronic Kidney Disease Alone
Condition: Heart Failure
Interventions: Drug: BAY94-8862;   Drug: Eplerenone;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results
Indicates status has not been verified in more than two years